Duncan Haworth

Comparison of the Angiotensin II Receptor Antagonist Irbesartan With Atenolol for Treatment of Hypertension

K. O. Stumpe, Duncan Haworth, Christer Höglund et al. · Blood Pressure · 1998 · 58 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Anti‐inflammatory activity of c(ILDV‐NH(CH₂)₅CO), a novel, selective, cyclic peptide inhibitor of VLA‐4‐mediated cell adhesion

Duncan Haworth, Amanda Rees, Peter J. Alcock et al. · British Journal of Pharmacology · 1999 · 34 citations · Full text

Life Sciences, Immunology, Pharmacology +17

A Double-Blind Comparison of Moxonidine and Atenolol in the Management of Patients with Mild-to-Moderate Hypertension

B. N. C. Prichard, Richard L. Simmons, Marie J. Rooks et al. · Journal of Cardiovascular Pharmacology · 1992 · 33 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Comparison of the effects of xamoterol and isoprenaline on rat cardiac β‐adrenoceptors: studies of function and regulation

Margaret Kowalski, Duncan Haworth, Xianyou Lu et al. · British Journal of Pharmacology · 1990 · 25 citations · Full text

Medicine, Cardiology, Pharmacology +13

Potent cyclic peptide inhibitors of VLA-4 (?4?1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-d-Arg-d-Arg) (ZD7349) compatible with depot formulation

Anand S. Dutta, James J. Gormley, Matthew Coath et al. · Journal of Peptide Science · 2000 · 20 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17